Genprex, Inc. vs. Corcept Therapeutics Incorporated – Trademark Opposition TTAB Proceeding 91277985

This Opposition was filed at the USPTO Trademark Trial and Appeal Board (TTAB) on August 16, 2022 and assigned serial number 91277985 by the TTAB.

Plaintiff:
Genprex, Inc. represented by MICHAEL J LEONARD of FOX ROTHSCHILD LLP.
Trademark Information: REQORSA – US Trademark Serial Number 90086499
View Trademark Status at USPTO
View Trademark Documents at USPTO

Defendant:
Corcept Therapeutics Incorporated represented by JOEL FELDMAN of GREENBERG TRAURIG LLP.
Trademark Information: REKORJA – US Trademark Serial Number 90901576
View Trademark Status at USPTO
View Trademark Documents at USPTO

Prosecution History:
August 16, 2022 – FILED AND FEE
August 16, 2022 – NOTICE AND TRIAL DATES SENT; ANSWER DUE:
August 16, 2022 – INSTITUTED
September 21, 2022 – D MOT FOR EXT W/ CONSENT
September 21, 2022 – EXTENSION OF TIME GRANTED
October 24, 2022 – D APPEARANCE / POWER OF ATTORNEY
October 24, 2022 – D CHANGE OF CORRESP ADDRESS
October 25, 2022 – ANSWER AND COUNTERCLAIM ( FEE)
October 27, 2022 – TRIAL DATES RESET
December 02, 2022 – ANSWER TO COUNTERCLAIM
December 09, 2022 – D REQ FOR DISCOVERY CONFERENCE-ESTTA
December 21, 2022 – TRIAL DATES REMAIN AS SET
April 07, 2023 – MOT TO AMEND ANS OR COUNTERCLAIM/AMENDED ANS OR COUNTERCLAIM
April 26, 2023 – D MOT TO SUSP W/ CONSENT PEND SETTL NEGOTIATIONS
May 01, 2023 – SUSPENDED
May 25, 2023 – D MOT TO SUSP W/ CONSENT PEND SETTL NEGOTIATIONS
May 30, 2023 – SUSPENDED
View this TTAB Proceeding at USPTO

About Select IP
Select IP Law Corporation monitors TTAB proceedings that have been instituted. We are experts in trademark law. If you are interested in connecting with an IP law attorney or patent law attorney, please contact us via the contact form.